Currently this content is only available in German.
Dieser Inhalt ist momentan nur auf Deutsch verfügbar.
0900 712 712
(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. in the waiting loop by network operator)
0900 712 713
(3.12 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. in the waiting loop by network operator)
Notfallnummern
Emergency Contact 24h
0900 712 712
(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. by network operator)
0900 712 713
(3.12 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)
Important Numbers
- 144 Ambulance
- 145 Tox Center (Poisoning)
- 117 Police
- 118 Fire Department
Kontakt Box
UKBB
University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel
Switzerland
T +41 61 704 12 12
Contact
For making an appointment or the postponement of an appointment, please contact polyclinic head office +41 61 704 12 20
Collection / Reminder
Patient invoice
Please contact me
Other
Prof. Johannes van den Anker, MD, PhD
Medical Director ASC
Senior Physician Pediatric Pharmacology
Personal Data
Date of Birth | May 11, 1957 |
Nationality | Dutch and American |
Family Status | Married, 1 child |
Training
1995 | Ph.D. Pediatric Pharmacology, Erasmus University, Rotterdam, NL |
1991 | Specialisation - Neonatal Medicine |
1988 |
Specialisation - Pediatrics |
1983 |
MD, Erasmus University, Rotterdam, NL |
Professional Postions
2002-2014 | Head of Division of Pediatric Pharmacology and Professor of Pediatrics, Pharmacology & Physiology, Children’s National Medical Center, Washington, DC, USA |
1997-2002 | Head of Division of Neonatal Medicine and Professor
of Pediatrics and Neonatology, Erasmus Medical Center/Sophia Children’s
Hospital, Rotterdam, NL |
1991-1997 | Consultant Neonatal Medicine, Erasmus Medical Center/Sophia Children’s Hospital, Rotterdam, NL |
1989-1991 | Fellowship Neonatal Medicine, Erasmus Medical Center/Sophia Children’s Hospital, Rotterdam, NL |
1988-1989 | Chief Resident, Erasmus Medical Center/Sophia Children’s
Hospital, Rotterdam, NL |
1984-1988 | Clinical training, Pediatrics, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, NL |
Acquisition of Research Funds (selection)
Principle investigator: Washington D.C. Collaborative PPRU, NIH/NICHD, 5U10HD045993
Principle investigator: Optimizing Pain Treatment in the Preterm Infant, NIH7NCRR, 5K24RR019729
Principle investigator: Optimizing the use of Morphine in Preterm Infants, NNIH/NICHD,
5RO1HD048689-01A1
Principle investigator: Optimizing the use of Methadone in Newborn Infants, NIH/NIDA, 5K24DA027992
Principle investigator: Metabolism and Toxicity and Efficacy in Longterm Systemic Treatment with Antisense, NIH/NICHD, 5U54HD071601
Co-applicant for FP7-EU grants: TINN, TINN2, NEUROSIS, GRIP
Distinction (selection)
2012 | Distinguished Researcher Award from the George Washington University School of Medicine and Health Sciences, Washington, DC, USA |
2008 | Distinguished Investigator Award from the American College of Clinical Pharmacology |
Review Activites
2014-present | Topic Editor Youth Clinical Therapeutics |
2013-present | Editor-in-Chief Current Therapeutic Research |
2013-present | Associate Editor Journal of Pediatric and Neonatal Individualized Medicine (JPNIM) |
2012-present |
Section Editor Pediatric Pharmacology of the International Journal of Clinical Pharmacology and Therapeutics |
2012-2015 | Secretary of the American College of Clinical Pharmacology |
2011-present | Associate Editor of Expert Review of Clinical Pharmacology |
2011-2017 | Member of the American Academy of Pediatrics Committee on Drugs |
2011-2017 | Member of the American Academy Section on Clinical Pharmacology and Therapeutics |
2010-2015 | Member of the American College of Clinical Pharmacology |
2006-2008 | President of the European Society for Development, Perinatal and Pediatric Pharmacology |
2005-2008 | Member of the Board of Direcotrs of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) |
Reviewer | New England Journal of Medicine, Pediatrics, JAMA, Journal of Pediatrics, Clinical Pharmacology and Therapeutics, Clinical Pharmacokinetics, Therapeutic Drug Monitoring, Antimicrobial Agents & Chemotherapy, Critical Care Medicine, American Journal of Obstetrics and Gynecology |
Contact
Prof. Johannes van den Anker, MD, PhD
Medical Director ASC
Head of Pediatric Pharmacology
Research
Research group: Pediatric Pharmacology and Pharmacometrics Research Center
Publications via Pubmed
Emergencies
0900 712 712
(3.23 CHF/min. CH-landline, possibly additionally 8 Rp. / min. by network operator)
0900 712 713
(3.12 CHF/min. prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)
Contact
University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland
T +41 61 704 12 12
Contact
Treatment & Hospitalisation
Research
Medicine
Career
The UKBB
Legal Requirements
Emergency
Contact
University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland
T +41 61 704 12 12
Contact
© UKBB, 2021